(Q56928597)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7484852%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

title

Frequency, significance, and cost of recurrent ischemia after thrombolytic therapy for acute myocardial infarction. TAMI Study Group (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7484852%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1 reference

myocardial infarction

1 reference

based on heuristic

inferred from title

acute myocardial infarction

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7484852%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

3

E J Topol

1 reference

19 October 2019

5

D J Kereiakes

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7484852%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

6

B S George

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7484852%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

10

R M Califf

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7484852%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

Christopher B. Granger

2

object named as

C B Granger

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7484852%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

author name string

A Barbagelata

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7484852%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

S J Worley

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7484852%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

E M Ohman

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7484852%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

J D Leimberger

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7484852%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

language of work or name

English

0 references

publication date

1 November 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7484852%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

19 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7484852%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

volume

76

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7484852%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

issue

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7484852%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

page(s)

1007-1013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7484852%20AND%20SRC:MED&resulttype=core&format=json

Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock

19 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980285-9

Characteristics and outcome of patients in whom reperfusion with intravenous tissue-type plasminogen activator fails: results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) I trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980285-9

Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980285-9

An analysis of the cause of early mortality after administration of thrombolytic therapy. The Thrombolysis Angioplasty in Myocardial Infarction Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980285-9

Occurrence, characteristics and prognostic significance of early postacute myocardial infarction angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980285-9

Early postinfarction ischemia: clinical, angiographic, and prognostic significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980285-9

Recurrent myocardial infarction: clinical predictors and prognostic implications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980285-9

High mortality early reinfarction with first nontransmural myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980285-9

A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980285-9

Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980285-9

A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980285-9

Results of high dose intravenous urokinase for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980285-9

Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction. Results of thrombolysis and angioplasty in myocardial infarction--phase 5 randomized trial. TAMI Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980285-9

Accelerated plasminogen activator dose regimens for coronary thrombolysis. The TAMI-7 Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980285-9

The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980285-9

Prognostic significance of early ischemia after acute myocardial infarction in low-risk patients. IRES (Ischemia Residua) Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980285-9

Recurrent ischemic events after successful thrombolysis in acute myocardial infarction. The Achilles' heel of thrombolytic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980285-9

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980285-9

Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. TIMI II A results. The TIMI Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980285-9

Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980285-9

Continuous 12-lead ST-segment recovery analysis in the TAMI 7 study. Performance of a noninvasive method for real-time detection of failed myocardial reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980285-9

Noninvasive assessment of speed and stability of infarct-related artery reperfusion: Results of the GUSTO ST segment monitoring study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980285-9

Prediction of early recurrent myocardial ischemia and coronary reocclusion after successful thrombolysis: A qualitative and quantitative angiographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980285-9

Early angiography cannot predict postthrombolytic coronary reocclusion: observations from the GUSTO angiographic study. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980285-9

Recurrent ischemia without warning. Analysis of risk factors for in-hospital ischemic events following successful thrombolysis with intravenous tissue plasminogen activator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980285-9

Incidence and predictors of early recurrent ischemia after successful percutaneous transluminal coronary angioplasty for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980285-9

Treatment of recurrent ischemia after thrombolysis and successful reperfusion for acute myocardial infarction: effect on in-hospital mortality and left ventricular function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980285-9

Predictors and long-term prognostic significance of recurrent infarction in the year after a first myocardial infarction. SPRINT Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980285-9

Left ventricular ejection fraction may not be useful as an end point of thrombolytic therapy comparative trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980285-9

Pharmacodynamics of thrombolysis with recombinant tissue-type plasminogen activator. Correlation with characteristics of and clinical outcomes in patients with acute myocardial infarction. The TAMI Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980285-9

Plasma fibrinopeptide A levels in patients with acute myocardial infarction treated with alteplase. Correlation with concomitant heparin, coronary artery patency, and recurrent ischemia. The European Cooperative Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980285-9

10.1016/S0002-9149(99)80285-9

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7484852%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1 reference